Climate nonprofits and public sector entities take up new roles on pharma issues

Foundations and charities are advocating for policies that incentivise sustainable practices throughout the drug lifecycle. They are crucial in research, focusing on areas like developing climate-resilient crops for drug ingredients and creating affordable healthcare solutions for vulnerable populations disproportionately affected by climate-driven health issues. They support the industry to adapt to prioritise environmental responsibility and equitable access to medication.

• The  H3D Foundation collaborates with the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) to boost the skills and capacity needed to drive increased research and development of new medicines in Africa. 

• The African Pharmaceutical Technology Foundation (APTF) aims to improve Africa's access to medicine by facilitating legitimate access to intellectual property and technology where African countries can produce essential medicines without limitations imposed by patents on the original drugs. 

In 2023, AFD Group's private sector arm, Proparco, dedicated over half of its activities (52%) to supporting African development across various sectors. Climate action remained a key focus area, representing 40% of their commitments, including initiatives to boost vaccine production capacity in Africa.